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Abstract 
Aims: The purpose of this thesis was to synthesize the current literature on alpha amylase as an 
emerging biomarker of microaspiration in mechanically ventilated patient.  
Methods:  The methodology included a review and synthesis of pertinent research articles from 
1981-2018, written in English language. Criteria for inclusion in the review were all articles that 
evaluated α- amylase in tracheal secretions or bronchoalveolar lavage fluid (BAL) as a 
diagnostic tool for identifying microaspiration. The search yielded 11 studies that were reviewed. 
Findings: The findings suggest that once aspiration occurs, the duration of α-amylase in the 
lungs requires further exploration to assist in interpretation of positive values. After these values 
are identified they need be used consistently used throughout practice of mechanically ventilated 
patients. Inconsistencies in the defining parameters of α-amylase were used with the thirteen 
studies.  
Conclusion:  Testing amylase levels can require financial stability, standardized training, and 
timeliness of collecting the specimen. Alpha-amylase is a biomarker of microaspiration. Further 
research should be conducted to evaluate the biomarker capabilities of α-amylase to assist in 
early identification and/or prevention of microaspiration in mechanically ventilated patients. 
Implications for nursing policy practice, education, and considerations for upcoming research of 
α-amylase were reviewed with limitations to the study. 
Key words:  Mechanical ventilation, nursing, ventilator associated events, pneumonia, α-
amylase, aspiration biomarker, aspiration 
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INTRODUCTION 
 
Microaspiration is a potentially serious complication that can occur in intubated patients 
who are in critical conditions. Microaspiration entails the seepage of subglottic secretions around 
the endotracheal tube (ETT) (Blot, Poelaert, and Kollef, 2014; Nseir, Zerimech, Jaillette, Artru, 
& Balduyck, 2011), VAP results in increased lengths of stay in the intensive care unit (ICU) and 
hospital and requires a team of ICU staff to provide around the clock care to affected patients. 
Rather than focus on VAP, current practice is to monitor for complications known as Ventilator 
Associated Events (VAE). VAE occur from a decline in oxygenation after a patient has 
previously stabilized, positive cultures of a respiratory infection, and diagnostic tests indicating 
infection or inflammation of the lungs (Center for Disease Control and Prevention, 2018). 
Critically ill patients are susceptible to aspirating on their own oral secretions while confined in 
their hospital beds (VanBlarcom & McCoy, 2018). Microaspiration can cause damage and 
contamination to the respiratory tract. This can leave patients with various secondary diseases: 
decreased cardiac output, respiratory alkalosis, increased intracranial pressure (ICP), distended 
abdomen, pneumothorax, and hospital- acquired infections, among other issues (Drašković & 
Rakić, 2011). The secretions that seep past the ETT tube may be found within the lungs of 
patients on mechanical ventilators.  
Amylase is an enzyme that is found usually in saliva or pancreatic secretions. Amylase 
converts starch into simple sugars inside the body (Medline, 2019). Patients are susceptible to 
many infections and complications when they are on a ventilator. More research needs to be 
conducted on the prevalence of α-amylase when found in the lungs compared to other locations 
in the human body. As well as, what a safe amount of α-amylase to have in the body before it 
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becomes a problem. Patients can aspirate both oral and/or gastric secretions. Aspiration of oral 
contents may be identified by detecting levels of α-amylase on tracheal secretion. Patients with 
α-amylase do not have protocols in place to identify the degree of severity in their lungs. α-
amylase has been associated with patients who have experienced microaspiration (Dewavrin et 
al, 2014).  
New research is suggesting α-amylase in tracheal secretions as a potential biomarker for 
detection of microaspiration of secretions around a breathing tube into the lungs; however, 
defined limits of its use have not been described. Few studies have acknowledged α- amylase as 
an imperative biomarker for aspiration pneumonia patients (Rouzé, Jaillette, and Nseir, 2018).
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Purpose 
 
The purpose of this thesis was to analyze the research that has been conducted on α-amylase in 
tracheal secretions of intubated patients.  
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METHOLODGY 
A literature search was conducted, and findings are reported as a literature review. 
Multiple databases were searched:  MEDLINE, CINAHL, PsycInfo and Academic Search. Key 
terms used were, “alpha-amylase or amylase* OR (MH "Amylases") AND (MH "Biological 
Markers") OR marker* or "bio* marker" or biomarker*) AND (aspirat* or Suctioning or 
bronch* or pulmonary or endotracheal or ventilat*. There were no restrictions on publication 
dates. Inclusion criteria consisted of the English language. All articles with α- amylase as a 
diagnostic tool for identifying microaspiration and indicators of α-amylase in bronchoalveolar 
lavage fluid (BAL) were included.  
From the original search with MEDLINE, CINAHL, PsycInfo, and Academic Search, 
(n= 77) articles were identified. Articles excluded discussed various properties of α-amylase with 
investigative research on preventing various medical conditions and their complexities that 
follow asthma, organ failure, high-intensity stress, and motor vehicle accidents. Articles were 
excluded due to not meeting the inclusion criteria (n = 68) of relating specifically to 
mechanically ventilated patients. Articles specific to amylase and its clinical significance in 
ventilated patients (n=9). Additional studies were found through review of article reference lists 
(n=2). A total of eleven studies were included in this review. These eleven articles that discussed 
α-amylase in ventilated patients were further investigated for their credibility in this literature 
review. 
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FINDINGS 
A comprehensive review of literature findings was completed to discuss the role of α- 
amylase as a biomarker for aspiration and complications of ventilation. Dewarvin et al, (2014) 
compared α-amylase levels in 109 patients in an ICU in a retrospective analysis. Of the patients 
that were included in the study there was 1055 tracheal aspirates. The value of a tracheal aspirate 
of α-amylase in a patient was >1688 IU/L to be deemed positive (Dewarvin et al, 2014).  
Weiss et al (2011), measured α-amylase in 296 BAL specimens from 280 patients that 
classified with a minimum of one risk factor of aspiration. These risk factors were difficulty 
swallowing, a decreased level of consciousness, cardiac infarction, a problem while being 
intubated, and vomiting within sixty minutes of an ETT tube being placed. The values that were 
used for this study were based off three categories of patients. One risk factor had 70 IU/L (22 
IU/L-17 IU/L; one risk factor, 253 IU/L (58 IU/L-623 IU/L), patients with a positive BAL gram 
stain (359 IU/L (154 IU/L-1453 IU/L) vs. 66 IU/L (26 IU/L-165 IU/L), p<0.001). Levels were 
higher in patients with a positive culture for bacteria, normal flora, or yeast compared to a 
negative culture, and patients with positive culture for bacteria, normal flora, or yeast 25.15 
IU/L[94 IU/L-832 IU/L] vs.63 IU/L [22IU/L], p<0.001 (Weiss et al, 2011). Individuals who 
were intubated for at least 72 hours were found to have α-amylase. Dewarvin et al and Weiss et 
al, suggested that measuring α-amylase was an efficient diagnostic tool that would allow for 
testing of critically ill patients.  
Samanta et al (2018) conducted a prospective observational study of 151 patients who 
were also intubated for at least 72 hours. α-amylase was evaluated in mini-BAL specimens and it 
was explored for association with VAP. OF the 151 patients 64.9% tested patients presenting 
with VAP. VAP patients had significantly higher median mini BAL α-amylase values than those 
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without VAP (287 IU/L vs. 94 IU/L, p<0.001). Patients that had none or up to 4 pre-intubation 
risk factors were 65 IU/L, 200 IU/L, 867 IU/L, and 3453 IU/L (p < 0.001). Median amylase in 
patients with 1 and 2 post intubation risk factors were 472 IU/L and 731 IU/L (p <0.001) 
(Samanta et al, 2018). 
One of the 11 articles included a population of children. Abu-Hasan et al, utilized 67 
chronically ill children with respiratory illnesses that needed a bronchoscopy (Abu-Hasan et al, 
2014). α-amylase was found to be significantly higher in bronchoalveolar lavage (BAL)of gram 
stains in positive BAL cultures (1,632 vs. 84 IU/L; p=0.049), and in positive BAL oral flora 
cultures (1,803 vs. 270 IU/L; p=0.004) (Abu-Hasan et al, 2014). 
Bai et al, expanded on the findings of the research Weiss et al (2013) investigating the 
effect of α-amylase an indicator of aspiration. The study included 280 mechanically ventilated 
patients of these 296 BAL samples were accumulated (Bai et al, 2013). The predictors of high 
amylase had a limit of 125 IU/L (Bai et al, 2013). Bronchial secretions were also analyzed in a 
study with Bain, Clarke, Davies, Levin, and Lamber (1981). The patient population was 21 
adults who acquired transtracheal aspiration chest infections. This exploratory/observational 
study found that amylase activity was 50,000 IU/L. 
In France there were 10 ICU’s that were incorporated into a study conducted by Jaillette, 
et al. Pepsin and α-amylase were evaluated in 2739 tracheal aspirates from 303 patients in the 
hospitals. Amylase levels that were > 1685 IU/mL in >30% of tracheal aspirated per patient 
(Jaillete et al, 2017). A prospective study was initiated that comprised of 26 intubated patients 
that were sedated for at least 48 hours and had a HiLo ETT (Filloux et al, 2019). These 26 
patients were considered a high risk for microaspirating. The oral amylase group compared 
between intubation groups of tracheal and subglottic study groups, oral had the highest numbers 
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of amylase accumulation of (307,606 [200,725-461,300] IU/L). Tracheal amylase was decreased 
in the control group of intubated patients where group where the median values IQR were as 
follows (191 [10–917] vs 6661 [2774–19,358] IU/L, p <0.001). Subglottic amylase levels were 
(130,750 [55,257-157,717] IU/L (Filloux et al, 2019). 
There were 15 patients that were mechanically ventilated with Shiley tracheostomy on 
low pressure and high-volume settings participated in a study on alpha-amylase activity in 
tracheobronchial secretions (Nandapalan et al, 1995). The α-amylase ranges that were used were 
(35-1125 IU/L; median 295 IU/L (Nandapalan et al, 1995). A retrospective analysis of 147 
elderly patients associated with VAP were grouped into a study by Qu et Al (2018). Their 
analysis revealed that patients with 3 or more risk factors for having a complication that required 
intubation, having a Glasgow coma scale score of <8, without subglottic secretions, and had α-
amylase levels of >4,681.5 IU/L (Qu et al, 2018).  
Sole et al (2014) conducted a descriptive study to review the existence of pepsin and 
amylase in oral-tracheal secretions of mechanically ventilated adult patients. From a study not 
yet published levels of aspiration of α-amylase were no aspiration (0 to 392 IU/L), low aspiration 
(392 to 1,499 IU/L), moderate (1,500 to 4,999 IU/L), high (> 5,000 IU/L). These levels were 
used to categorize patients for risk for complications from a different study (Sole, et al 
unpublished data). 
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DISCUSSION 
 
Each of these articles utilized a different range of values to help quantify the amount of 
α-amylase in patients’ secretions. Filloux et al, had used oral, subglottic, and tracheal secretions 
of α-amylase to determine the difference in each section of the upper airway. Whereas, 
Dewarvin, Weiss, Bain, and Abu-Hassan focused on the location of BAL secretions. A weakness 
in Dewarvin’s study included their sample size of tracheal aspirates from patients and that their 
cut-off range of 1688 IU/L could have falsely reinforced the results. The patients that were on 
the ventilators in the hospital also did not have their markers for microaspiration consistently 
trended during their hospital stay (2014). Sole et al, reiterates that microaspiration of oral and 
gastric secretions occur often even though pepsin was more commonly detected in the 2014 
study. Qu et al, found that α-amylase can be a prognostic tool for identifying VAP. The higher 
the levels of tracheal aspirates the higher the likelihood of VAP occurring. Tracheal aspirate α-
amylase levels exceeded more than 4681.5 IU/L elderly patients. 
An acceptable level of secretions containing α-amylase must be established to set 
standardized parameters in practice (Gatell et al, 2012). Samanta et al, agrees that the lack of a 
gold standard limits the diagnosis for aspiration. Small sample sizes of intubated patients need to 
be expanded to further validate α-amylase analytic abilities. Once aspiration occurs, the duration 
of α-amylase in the lungs requires further exploration to assist in the interpretation of positive 
values. Researchers are still unaware of how long α-amylase occurs in the lungs which calls for 
uncertainty of its destruction leading to VAP. An exact range for positive aspiration has yet to be 
defined. 
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IMPLICATIONS FOR NURSING 
Education 
 Currently nursing education in some areas does not consist of information on α-amylase 
and its biomarker capabilities. As evidence-based practice continues to be updated in the 
research setting this information needs to be transferred from the bedside to the classroom. 
Student nurses have a right to be informed and brought in on new data. Nurses swear an oath to 
become a patient advocate. A part of being a patient advocate means knowing the best possible 
form of treatment. Hospitals have nurse educators who are constantly providing informational 
packets and assignments to nurses to have current EBP. However, there are no values being 
taught in the hospitals for nurses to look for because more research must be done to find how 
significant these values are. 
Practice 
 Applying α-amylase in the nursing profession requires commitment of the nurses and the 
hospitals to regulate the values of α-amylase. Once aspiration occurs, the duration of α-amylase 
in the lungs requires exploration to assist in the interpretation of positive values. This means that 
more work needs to be done to have an established cutoff level of α-amylase. An established 
cutoff level will facilitate comparison of patient populations, interventions, and outcomes. 
Research 
Weiss et al, stated that more research needs to be conducted on α-amylase as a biomarker 
for microaspiration (2013). At risk patients that have private health information such as a history 
of HIV/AIDS or risk factors that are unknown are unable to be identified within the hospital 
setting to prevent ventilator associated events (VAE) and VAP. Further funding would need to be 
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provided for researchers to continue the development of α-amylase as a biomarker for 
microaspiration. 
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SUMMARY 
More research is needed to associate α-amylase as a primary biomarker for assessing for 
aspiration and look at risks for pulmonary complications, such as VAP. There is not enough 
education in the field of nursing on this topic to create a standard competency. More information 
on the universal diagnostic ranges of α-amylase need to be investigated further. Financial 
stability, regulated training, and suitability of gathering samples are potential barriers to a 
prospective life changing implementation. Though these barriers can seem vastly inaccessible for 
individuals in healthcare research, the outcomes can outweigh these factors.  
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FIGURE Ⅰ: PRISMA FLOW CHART 
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Articles were identified after an initial screening of the 
following databases with key search terms. (CINAHL, 
PsychINFO, Academic Search Premiere, MEDLINE) 
(n = 77) 
 
Articles were excluded 
due to not meeting the 
inclusion criteria 
(n = 68) 
 
These studies were reviewed, hand selected 
for use, included the inclusion criteria, and 
were specific to the current focus for the 
study 
(n = 11) 
 
Articles specific to amylase 
and its clinical significance in 
ventilated patients 
(n=9) 
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Study  Purpose Sample 
Size 
Study Design Methodology and Instruments Findings and Conclusions Comments/Limitations 
Abu-Hasan M, 
Elmallah M, Neal 
D, Brookes, J. 
Salivary amylase 
level in a 
bronchoalveolar 
fluid as a marker of 
chronic pulmonary 
aspiration in 
children. Pediat 
Aller Imm Pul. 
2014;27(3), 115-
119. 
Explore the use 
of salivary 
amylase in 
bronchoalveolar 
lavage (BAL) 
fluid as a 
diagnostic tool 
for chronic 
pulmonary 
aspiration 
(CPA) in 
children 
64 children 
with 
chronic 
respiratory 
illness 
requiring 
bronchosco
py were 
included. 
 
A 
retrospective 
review of 
BAL amylase 
and medical 
records. 
Amylase in BAL fluid was 
measured by a functional assay 
using photometric techniques. 
Analysis of variance, Student’s t-
test, logistic regression analysis, 
and correlation analysis was 
utilized to assess statistical 
significance.  
Patient clinical and demographic 
variables were analyzed using 
multiple regression analysis to 
determine any impact on BAL 
amylase. 
When the high and low-risk 
groups were combined, a 
significant difference (p=.03) 
(higher amylase levels of 
1,722 vs. 307 IU/L) was 
noted compared to the 
remaining group.  
BAL amylase was 
significantly higher in the 
following groups: positive 
BAL gram stains (1,857 vs. 
479 IU/L; p=0.014), in 
positive BAL cultures (1,632 
vs. 84 IU/L; p=0.049), and in 
positive BAL oral flora 
cultures (1,803 vs. 270 IU/L; 
p=0.004). 
Variability in amylase 
levels existed among 
groups, potentially due 
to equipment 
contamination with 
upper airway secretions 
and/or acute aspiration 
during the 
bronchoscopy. 
 
 It is impractical to fully 
generalize results of 
children to adults due to 
differing variables (i.e., 
young age and inevitable 
aspiration). 
 
Standardization of and 
collection of urea levels 
are suggested in the 
BAL collection process 
to reduce variability. 
 
Bai C, Liu J, Song 
Y. Amylase in 
bronchoalveolar 
lavage fluid: a new 
marker of 
pulmonary 
aspiration. Critical 
Care Med. 
2013;41(3), 916-
917. 
To discuss the 
findings of 
Weiss et al. 
(2013) 
exploring the 
impact of α-
amylase as a 
predictor of 
aspiration. 
280 
mechanical
ly 
ventilated 
patients 
from five 
medical 
centers 
were 
included. 
Of these 
This study 
provided an 
overview of 
Weiss et al. 
(2013) and 
the 
retrospective 
study design 
utilized. 
The correlation between BAL 
amylase concentration, BAL 
microbial culture results, and pre-
intubation aspiration risk factors 
were assessed. 
A strong association existed 
between BAL amylase and 
risk factors for aspiration. 
With a BAL amylase 
concentration cutoff of < 125 
IU/L, the sensitivity was 
70% for predicting bacterial 
pneumonia (negative 
predictive value of 85%).  
 
No, a “gold standard” 
exists for diagnosis of 
bacterial pneumonia. 
Due to the evolving 
nature of BAL amylase, 
several measurements 
should be done rather 
than one.  BAL amylase 
collection requires 
training (requiring time 
and financial resources).  
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Study  Purpose Sample 
Size 
Study Design Methodology and Instruments Findings and Conclusions Comments/Limitations 
patients, 
296 BAL 
samples 
were 
collected. 
A standardization of 
collection mechanisms 
for BAL amylase 
(collection volume and 
location) is 
recommended. 
Bain B.C, Clarke 
P.D, Davies A, 
Levin G.E, Lamber 
H.P. Aspiration in 
seriously ill 
patients: A study of 
amylase in 
bronchial 
secretions. Journal 
of Clinical 
Pathology, 
1981;34, 803-805. 
To explore the 
increased levels 
of amylase 
activity in the 
bronchial 
secretions in 
patients in the 
ICU. 
 
21 patients 
with 
moderate to 
severe 
chest 
infections 
were 
obtained by 
transtrache
al 
aspiration. 
 
Exploratory/o
bservational 
Quantitative 
 
ES was collected either 
immediately before or during the 
TTA procedure in alert patients, 
but pharyngeal suction specimens 
were used in some of the seriously 
ill patients. Specimens were stored 
at + 4°C for a variable period of 
up to three weeks before 
estimation of the amylase 
activities. Sera taken at the time of 
the procedure were stored at - 
20°C for similar periods before 
analysis. The specimens were 
diluted and homogenized with 
dithiothreitol. 
 
In seriously ill patients the 
mean TTA amylase activity 
was 50 000 IU/L while in the 
less ill patients it was 1565 
IUL (p < 0 0005). The mean 
ES amylase activity was 206 
000 IU/L. The mean serum 
amylase activity was 260 
IU/L. Although TTA is a 
valuable diagnostic method 
in difficult pulmonary 
infections, contamination by 
oropharyngeal flora is not 
uncommon and will cause 
difficulties of interpretation. 
The second findings serve as 
a reminder of the frequency 
and importance of aspiration 
in seriously ill patients.  
 
The reproducibility of 
this method for 
estimating amylase in 
sputum and tracheal 
aspirate is poor, partly 
due to the lack of 
homogeneity of the 
samples, and partly to 
the difficulty of pipetting 
viscous material, with a 
coefficient of variability 
of 27% on nine paired 
samples. 
The seriously ill patients 
(6/21) had all undergone 
pharyngeal suction and 
nasogastric intubation as 
routine nursing 
procedures in the ICU; 
these procedures could 
have yielded to the high 
levels of amylase 
activity found in TTA 
samples. Compared to 
the fifteen who were not 
given the same 
treatments. 
Dewavrin F, 
Zerimech F, Boyer 
A, et al. Accuracy 
The purpose of 
this study was 
to determine the 
1055 
tracheal 
aspirates, 
Retrospective 
analysis of 
prospectively 
Pepsin was quantitatively 
measured in all tracheal aspirates 
during a 48-h period. All tracheal 
Mean α-amylase level, and 
percent of tracheal aspirates 
positive for α-amylase were 
The use of α-amylase as 
a diagnostic tool for 
microaspiration is 
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Study  Purpose Sample 
Size 
Study Design Methodology and Instruments Findings and Conclusions Comments/Limitations 
of α-amylase in 
diagnosing  
microaspiration in 
intubated critically 
ill patients. Plos 
One. 2014;9(3), 
e90851. 
 
accuracy of α-
amylase in 
diagnosing 
microaspiration 
in critically ill 
patients. 
collected 
from 109 
patients. 
collected 
data. 
aspirates were frozen and later 
tested for α-amylase. 
Microaspiration was defined as 
the presence of at least one 
positive tracheal aspirate for 
pepsin (>200 ng/mL). Abundant 
microaspiration was defined as the 
presence of pepsin at a significant 
level in >74% of tracheal 
aspirates. 
significantly higher in 
patients with 
microaspiration, and in 
patients with abundant 
microaspiration compared 
with those with no 
microaspiration; and similar 
in patients with 
microaspiration compared 
with those with abundant 
microaspiration. 
α-amylase and pepsin were 
significantly correlated (R2 
=0.305, p=0.001). 
moderate.  It was found 
to be less conclusive 
when compared to 
pepsin and often 
inaccurate. 
Weaknesses include the 
sample size at a single 
institution, markers for 
microaspiration were not 
measured during the 
whole period of 
mechanical ventilation, 
and while the definition 
of microaspiration as the 
presence of pepsin at a 
significant level is likely 
correct, this only applies 
to aspiration of gastric 
contents. This could 
have altered the accuracy 
of the assessment. The 
cut-off of 1688 IU/L 
might have artificially 
strengthened the results. 
Filloux B, Bedel A, 
Nseir S. Tracheal 
amylase dosage as 
a marker for 
microaspiration: a 
pilot study. 
Minerva 
Anestesiol. 
2013;79(9), 1003-
1010. 
 
Assess the 
ability to use α-
amylase as a 
diagnostic tool 
in quantifying 
microaspiration 
of oral 
secretions. 
(n=26) 
intubated 
high-risk 
patients 
yielded 277 
paired oral/ 
tracheal 
specimens. 
12 (n=12) 
non-
ventilated 
patients 
Prospective 
study 
Twenty-six patients were 
intubated for at least 48 hours 
with a subglottic suction ETT, 
were considered high risk of 
microaspiration. Twelve non-
ventilated patients that required a 
bronchoscopy made up the low-
risk control group. Tracheal (T) 
amylase was compared between 
the groups. In the intubated group, 
a series of oral (O), subglottic (Sg) 
and tracheal (T) suction samples 
Tracheal amylase was lower 
in the control group than the 
intubated group (191 [10–
917]  
Vs .6661 [2774–19,358] 
IU/L, p <0.001). Amylase 
gradually increased from 
tracheal (6661 [2774-19,358] 
IU/L), to subglottic (130,750 
[55,257-157,717] IU/L), to 
oral samples (307,606 
[200,725-461,300] IU/L), 
Amylase is a simple, 
stable, and inexpensive 
enzyme to measure, and 
gives reproducible 
results. Beyond the 
crude quantitative 
assessment of tracheal 
amylase, the 
tracheal/oral amylase 
ratio may enable 
quantification of 
microaspiration. 
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Study  Purpose Sample 
Size 
Study Design Methodology and Instruments Findings and Conclusions Comments/Limitations 
that 
required a 
bronchosco
py yielded 
12 paired 
specimens 
(the control 
group). 
were collected and T/O, T/Sg, 
Sg/O amylase ratios were 
determined. 
resulting in a median 5.5% 
T/O ratio.  
 
This study indicated that T/O 
amylase ratio could be used 
towards quantifying 
microaspiration of oral 
secretions in mechanically 
ventilated patients. 
 
Limitations include 
contamination of the 
tracheal secretions with 
oral secretions during the 
bronchoscopy, the use of 
an open tracheal 
suctioning system, and 
the study’s limited 
collection centers and 
subject number. 
Jaillette, E., 
Brunin, G., Girault, 
C., Zerimech, F., 
Chiche, A., Behal, 
H., Chiche, A., . . . 
Nseir, S. (2017). 
Impact of tapered-
cuff tracheal tube 
on micro-aspiration 
of gastric contents 
in intubated 
critically ill 
patients: A 
multicenter cluster-
randomized cross-
over controlled 
trial study protocol 
for a randomized 
controlled trial. 
Intensive Care 
Medicine, 43, 
1562-1571.  
The aim of this 
study was to 
determine the 
influence of the 
shape of 
tracheal cuff on 
abundant 
microaspiration 
of gastric 
contents in 
critically ill 
patients. 
A total of 
326 
patients 
were 
enrolled in 
the ten 
participatin
g ICUs 
(162 in the 
PVC 
tapered-
cuff group 
and 164 in 
the 
standard-
cuff group 
Clustered 
randomized 
controlled 
trial 
In ten different French ICU’s 
patients who were older than 18 
that were intubated, had at least 48 
hours of mechanical ventilation, 
weren’t pregnant, could receive 
enteral feedings, and screened 
positive for 72 hours and over 
intubation were eligible for the 
study.  
A total of 326 medical 
patients were randomized in 
the 10 participating ICUs. 
Pepsin and salivary amylase 
were quantitatively measured 
in 2739 tracheal aspirates 
coming from 303 patients. 
Amylase levels >1685 IU/L 
in >30% of tracheal aspirates 
per patient were defined has 
an abundant amount. No 
tracheal secretions were 
present in 23 patients. The 
median number of tracheal 
aspirates per patient in which 
pepsin and salivary amylase 
were measured was similar 
in the two groups. 
 
Tapered-cuff tracheal 
tube was not superior to 
standard-cuff tracheal 
tube in reducing 
microaspiration of 
gastric contents. The 
results suggested that 
tapered-cuff tracheal 
tube should not be used 
to prevent 
microaspiration or VAP 
in ICU patients. 
Nandapalan, V., 
McIlwain, J. C., & 
Hamilton, J. A 
The aim of this 
study was to 
evaluate 
15 patients 
ventilated 
via a fresh 
Descriptive 
Study 
Tracheobronchial secretions were 
obtained from the patients on the 
first, second, and third days. 
Six out of the fifteen patients 
showed very high levels of 
amylase activity in their 
All but one of the 
patients developed a 
form of a chest infection. 
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Study  Purpose Sample 
Size 
Study Design Methodology and Instruments Findings and Conclusions Comments/Limitations 
study of alpha-
amylase activity in 
tracheobronchial 
secretions of 
seriously ill 
patients with 
tracheostomies. 
Journal of 
Laryngology and 
Otology, 1995; 
109, 640-643. 
 
salivary 
aspiration in 
seriously ill 
patients with 
tracheostomies 
and to see 
whether there 
was any 
correlation with 
subsequent 
development of 
chest infection. 
The presence of 
amylase in 
tracheobronchia
l secretion was 
used as an 
indicator of 
tracheobronchia
l contamination 
by saliva. 
tracheosto
my and all 
had Shiley 
tracheosto
my tubes. 
Patients 
had no 
clinical or 
radiologica
l evidence 
of lung 
disorder at 
the time of 
the study. 
Samples from the trach tube were 
collected via a sputum trap and a 
sample of saliva was gathered 
from each patient routinely. The 
specimens were sent to the lab to 
assess for alpha-amylase.  
 
Alpha-amylase activity in the 
samples was analyzed by the 
blocked substrate maltoheptaose 
method at 37°C. The presence of 
amylase in tracheobronchial 
secretion was used as an indicator 
of tracheobronchial contamination 
by saliva above and below the 
cuff. Chest xray changes, bronch 
findings, and partial pressure 
changes across alveolar 
membranes were looked at.   
 
The control was the alpha-
amylase in tracheobronchial 
secretions of patients who had 
normal lungs. 
tracheobronchial secretions 
and these levels increased 
from Day 1 to Day 3. 
Bacteriological culture of the 
sputum during the time of 
chest infection revealed that 
of the eight patients who had 
anaerobic organisms, five 
had clear evidence of 
aspiration. Three patients 
grew aerobic organisms and 
in three patients there was 
some growth of a mixed 
flora in the sputum but there 
was no significant 
pathological count. 
Of the patients studied; 
six were able to be 
confirmed infection from 
a salivary aspiration. 
Patients 1,2,3,4 and 5 
had an increase in the 
percentage ratio of 
tracheobronchial 
amylase to salivary 
amylase. As well as, in 
the absolute amylase 
levels in the 
tracheobronchial on Day 
3. It is likely that 
contamination of the 
trachea is beyond the 
cuff which could have 
led to chest infections 
amongst the patients. 
Since the chest 
infections are not always 
associated with salivary 
aspiration, the reason for 
severe chest infection in 
patients 7 and 13.  
Sole, M.L., 
Conrad, J., 
Bennett, M., 
Middleton, A., 
Hay, K., Ashworth, 
S., Devendra, I.M 
Pepsin and 
Amylase in oral 
and tracheal 
secretions: A pilot 
study. American 
To assess the 
presence of 
pepsin and 
amylase in 
paired oral-
tracheal 
secretions of 
adult patients 
being treated 
with 
10 men and 
3 women 
with a 
median age 
of 56 years. 
Majority 
were 
intubated 
with a 
subglottic 
suction 
Descriptive 
Design Study  
In this descriptive study, samples 
of oral and tracheal secretions 
were obtained from adult patients 
at baseline and again within 4 
hours when a need for 
endotracheal suctioning was 
assessed. Assays of pepsin and 
amylase were processed in a 
specialty diagnostic laboratory.  
 Pepsin was present in oral 
secretions of 9 patients 
(69%), and in tracheal 
specimens of 7 patients 
(54%) at one or both 
sampling times. Amylase 
was detected in all patients’ 
oral secretions and in 
tracheal secretions of 5 
patients (38%) at one or both 
sampling times. Pepsin was 
Micro-aspiration of oral 
and gastric secretions 
does occur frequently. 
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Journal of Critical 
Care, 23(4), 334–
338. 
 
 
mechanical 
ventilation. 
endotrache
al tube 
(69%); and 
85% were 
receiving 
enteral 
feedings 
with the 
majority 
(67%) 
gastric. 
more commonly detected 
than was amylase.  
Samanta S, Poddar 
B, Azim A, Singh 
RK, Gurjar M, 
Baronia AK. 
Significance of 
mini 
bronchoalveolar 
lavage fluid 
amylase level in 
ventilator-
associated 
pneumonia. 
Critical Care Med. 
2018;46(1),71-78. 
 
Assess if α-
amylase in 
mini-BAL 
specimens can 
be indicative of 
VAP in 
intubated 
patients with 
high clinical 
suspicion. 
151 
patients. 
Prospective 
single-
centered 
observational 
study. 
 
Mini-BAL samples were collected 
within 72 hours of endotracheal 
intubation.  
Samples were sent for α-amylase 
level assay and quantitative 
culture. VAP was confirmed with 
mini-BAL microbial cultures of 
greater than or equal to 10 
cfu/mL, and patients were divided 
into VAP and no VAP groups.  
Pre- and post-intubation risk 
factors for aspiration were 
assessed. 
Presence of VAP 64.9% 
(n=98) of the 151 patients. 
Median mini-BAL amylase 
levels in VAP group were 
287 IU/L and no VAP group 
94 IU/L, (p < 0.001). 
Median amylase level in 
patients with 0, 1, 2, and 3 
pre-intubation risk factors 
respectively were 65 U/L, 
200 IU/L, 867 IU/L, and 
3453 U/L (p < 0.001). 
Median amylase in patients 
with 1 and 2 post intubation 
risk factors were 472 IU/L 
and 731 IU/L (p <0.001). 
Patients with VAP have 
higher mini-BAL amylase 
levels than non-VAP and 
amylase levels increase with 
the number of risk factors. 
Limitations include the 
lack of a gold standard 
of diagnosis for 
aspiration, a single 
measurement of amylase 
may not reflect the 
actual clinical situation, 
oral care and 
endotracheal suctioning 
may increase the risk of 
aspiration, and the small 
sample size needs to be 
expanded to further 
validate α-amylase as a 
diagnostic tool. 
Qu G-P, Fang X-Q, 
Xu Y-P. Predictive 
Investigates 
correlations of 
147 elderly 
ventilated 
Retrospective 
analysis of 
Tracheal aspirates were collected 
from elderly patients within two 
α-amylase level increased 
with the amount of risk 
α-amylase can serve as a 
predictive tool for VAP. 
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value of a-amylase 
in tracheal 
aspirates for 
ventilator-
associated 
pneumonia in 
elderly patients. 
Clin Respir J. 
2018;12(4),1685-
1692. 
 
 
α-amylase in 
tracheal 
aspirates and 
aspiration risks 
with incidence 
of ventilator-
associated 
pneumonia 
(VAP) in 
elderly patients 
undergoing 
mechanical 
ventilation.  
Examines 
clinical value of 
α-amylase for 
predicting VAP. 
 
patients 
grouped 
based on 
the 
presence of 
VAP. 
 
prospectively 
collected 
data. 
 
weeks of tracheal intubation and 
α-amylase was assessed.  
Patients were placed in groups 
based on VAP diagnosis. 
Relationships between α-amylase 
and aspiration risks were assessed 
before intubation and VAP. 
 
 
factors for aspiration in place 
prior to intubation.  
α-amylase level was 
significantly higher in the 
VAP group than in the non-
VAP group. 
Logistic multivariate 
analysis revealed the 
following risk factors for 
VAP:  having >=3 risk 
factors before intubation, 
Glasgow scores of <8, the 
absence of continuous 
aspiration of subglottic 
secretion, and a tracheal 
aspirate α-amylase level of 
>4,681.5 IU/L. 
 
Regardless of the 
occurrence of VAP, 
tracheal aspirate α‐
amylase level increased 
with the increase in the 
number of risk factors 
for aspiration before 
intubation; tracheal 
aspirate α‐amylase level 
was significantly higher 
in VAP patients than in 
non‐VAP patients, 
wherein the higher the 
number of times the 
tracheal aspirate α‐
amylase value exceeded 
4681.5 IU/L, the higher 
the possibility of VAP 
was.  
α-amylase could work as 
a predictor of aspiration 
and VAP. 
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Size 
Study Design Methodology and Instruments Findings and Conclusions Comments/Limitations 
Weiss, C. H., 
Moazed, F., & 
Wunderink, R. G. 
Bronchoalveolar 
lavage fluid 
amylase is 
elevated in patients 
with a high risk of 
aspiration. 
American Journal 
of Respiratory and 
Critical Care 
Medicine, 2011; 
183, A3915. 
 
 
To determine 
whether 
amylase only 
produced in the 
salivary glands 
and 
gastrointestinal 
tract found in 
bronchoalveolar 
lavage fluid is 
associated with 
an increased 
risk of 
aspiration. 
591 
patients in 
an ICU 
Retrospective 
Study 
Nonbronchoscopic or 
bronchoscopic specimens were 
collected within 72 hours of 
endotracheal intubation. 
Collection of the data was done 
blinded and aspiration risk factors 
were included. Significance was 
determined by the Wilcoxon rank-
sum tests. Data was presented as 
interquartile range. 
Data from 93 patients of the 
591 were analyzed. Median 
BAL amylase was higher in 
patients with at least one 
aspiration risk factor 
compared to zero (264 
units/L. vs 70 IU/L, <0.001 
p). Median amylase 
increased as the number of 
aspiration risk factors 
increased. Median amylase 
was higher in patients with a 
positive BALF Gram stain, 
and higher in patients with a 
positive culture for bacteria, 
normal flora, or yeast 
compared to a negative 
culture (25.15 IU/L[94 IU/L-
832 IU/L] vs.63 IU/L [22 
IU/L], p<0.001). There was 
no difference in BAL 
amylase patients with a 
new/progressive pulmonary 
infiltrate vs. 
unchanged/improving 
infiltrate. 
 
Aspiration of 
oropharyngeal or gastric 
contents into the 
respiratory tract needs 
additional study. The 
diagnosis for aspiration 
was rather difficult due 
to the criteria of 
aspiration. Therefore, it 
was difficult to have 
statistical evidence from 
one etiology of 
aspiration.  
High levels of amylase 
in bronchoalveolar 
lavage fluid (BALF) 
fluids are associated with 
both increased risk of 
aspiration and evidence 
of microbial infection. 
Amylase may be useful 
tool for diagnosis 
aspiration. 
 
 
 
BAL, bronchoalveolar lavage; EBP, Evidence Based Practice; ES, Expectorated sputum ICU, intensive care unit; VAP, ventilator associated pneumonia
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